Trombola (Eltrombopag ) 25mg

Trombola (Eltrombopag ) 25mg

Trombola 25 mg contains Eltrombopag, a thrombopoietin receptor agonist used to treat conditions associated with low platelet counts. It is commonly prescribed for chronic immune thrombocytopenia (ITP), severe aplastic anemia, and thrombocytopenia related to chronic hepatitis C. Eltrombopag works by stimulating the bone marrow to produce more platelets, helping reduce the risk of bleeding.

Field Details
Original Brand Revolade
Generic Brand Trombola 25
Generic Name Eltrombopag 25 mg
Pack Size 28 Tablets (Typical Pack)
Use / Indications Immune Thrombocytopenia (ITP), Severe Aplastic Anemia, Hepatitis C-related Thrombocytopenia
Manufacturer Everest Pharmaceuticals Ltd. (Produced in Bangladesh)
Status Prescription Only Medicine
Quantity

Introduction to Promacta (Eltrombopag) 25mg 

Promacta (Eltrombopag) 25mg is a prescription medicine used to treat certain blood disorders associated with low platelet counts, such as chronic immune thrombocytopenia (ITP) and severe aplastic anemia. This medicine belongs to a class of hematology drugs that help stimulate platelet production in the bone marrow.

Promacta (Eltrombopag) 25mg is classified under Prescription Medicines, Hematology Medicines, Thrombopoietin Receptor Agonists, and Oral Platelet-Stimulating Therapies. It contains Eltrombopag, which works by activating specific receptors in the bone marrow to increase platelet production.

In some markets, Trombola 25mg is available as a generic brand containing the same active ingredient Eltrombopag, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.

What Is Promacta (Eltrombopag)? 

Promacta is the brand name for Eltrombopag, an oral medication widely used in the treatment of conditions that cause low platelet counts (thrombocytopenia).

Eltrombopag belongs to a class of medicines known as Thrombopoietin Receptor Agonists (TPO-RAs). These medicines help stimulate platelet production in the bone marrow, reducing the risk of bleeding in affected patients.

Generic versions such as Trombola 25mg contain the same active compound and may be used depending on physician recommendation and regional availability.

Drug Class and Mechanism of Action 

Eltrombopag is classified as a thrombopoietin receptor agonist with platelet-stimulating properties.

How Eltrombopag Works 

It works in several ways:

  • Activates thrombopoietin receptors in the bone marrow
  • Stimulates megakaryocyte growth and development
  • Increases platelet production in the bloodstream

Through these mechanisms, Eltrombopag helps increase platelet counts and reduce bleeding risks in patients with certain blood disorders.

How Promacta Works in the Body 

Low platelet levels can increase the risk of bruising and bleeding. Promacta helps restore platelet production by stimulating the body’s natural platelet-forming processes.

Key Actions of Eltrombopag 

  • Stimulating bone marrow cells responsible for platelet production
  • Increasing platelet counts to safer levels
  • Helping reduce bleeding complications

Some generic versions such as Trombola deliver the same active compound, allowing similar platelet-stimulating treatment when prescribed appropriately.

Medical Uses of Promacta (Eltrombopag) 25mg 

Promacta 25mg is commonly prescribed for several conditions related to low platelet counts.

Promacta for Immune Thrombocytopenia (ITP) 

For patients with chronic immune thrombocytopenia, Promacta helps increase platelet levels when other treatments such as corticosteroids or immunoglobulins have not been effective.

Potential Benefits 

  • Increased platelet count
  • Reduced risk of bleeding episodes
  • Improved quality of life for patients with chronic ITP

Generic alternatives like Trombola 25mg may also be used under medical supervision when Eltrombopag therapy is recommended.

Promacta for Severe Aplastic Anemia 

Promacta may also be used in patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy.

Treatment Benefits 

  • Improved blood cell production
  • Increased platelet levels
  • Better management of bone marrow failure disorders

Who Can Take Trombola 25mg? 

Because Eltrombopag is a potent medicine, treatment should always be supervised by an experienced healthcare provider.

Eligibility Criteria 

Patients may be prescribed Promacta if they:

  • Have chronic immune thrombocytopenia (ITP)
  • Have severe aplastic anemia
  • Need improved platelet production due to bone marrow disorders

Certain generic options such as Trombola may also be considered depending on availability and physician decision.

Who Should Avoid Promacta (Eltrombopag) 25mg 

Promacta should NOT be used by:

  • Individuals with hypersensitivity to Eltrombopag
  • Patients with severe liver impairment without medical supervision
  • Individuals with uncontrolled blood clotting disorders

Promacta (Eltrombopag) 25mg Dosage and Administration 

Standard Dosage Guidelines 

Typical dosage recommendations include:

  • Promacta 25mg once daily
  • Taken on an empty stomach or as directed by a physician
  • Tablets should be swallowed whole with water

Dosage Adjustments 

Doctors may adjust the dose depending on:

  • Platelet count monitoring
  • Liver function tests
  • Individual treatment response

Side Effects of Promacta 25mg 

Like all prescription medicines, Promacta may cause side effects.

Common Side Effects 

  • Headache
  • Nausea
  • Fatigue
  • Diarrhea

Serious Side Effects 

  • Liver Function Abnormalities
  • Blood Clots (Thrombosis)
  • Bone Marrow Changes

Patients should contact their doctor immediately if serious symptoms occur.

Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Frequently Asked Questions (FAQs) 

1. Is Promacta (Eltrombopag) 25mg used for low platelet counts? 

Yes. Promacta is commonly prescribed to increase platelet counts in patients with immune thrombocytopenia and other bone marrow disorders.

2. How long does it take for Eltrombopag to work? 

Many patients begin to see an increase in platelet counts within 1–2 weeks, though full therapeutic response may take longer.

3. Is Promacta chemotherapy? 

No. Promacta is not chemotherapy. It is a thrombopoietin receptor agonist that stimulates platelet production in the bone marrow.

4. Can Trombola 25mg be taken with food? 

Eltrombopag is usually taken on an empty stomach, as certain foods—especially those high in calcium—may reduce absorption.

5. Can pregnant women take Trombola 25mg? 

No. Trombola 25mg should only be used during pregnancy if clearly recommended by a physician due to potential risks.

6. Is Trombola 25mg the same as Promacta? 

Trombola 25mg contains Eltrombopag, the same active ingredient found in Promacta. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764

7. Do I need a prescription to buy Trombola (Eltrombopag) 25mg? 

Yes. Trombola 25mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Medical Disclaimer 

Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Promacta (Eltrombopag) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.

 

Let's Chat!